Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia F Borges

Showing results (31-40 of 154) with videos related to

Pageof 16
Sort By:
Appetite|December 20, 2022
The effects of resistance exercise on appetite sensations, appetite related hormones and energy intake in hormone receptor-positive breast cancer survivorsSarah A Purcell, Edward L Melanson, Anosheh Afghahi, et al.
Oncology (Williston Park, N.Y.)|September 20, 2015
Multiple Hepatic Lesions in a Patient With a History of DCISJagar Jasem, Basel Altoos, Christine M Fisher, et al.
Cancer Research|August 17, 2006
Spontaneous fusion with, and transformation of mouse stroma by, malignant human breast cancer epitheliumBritta M Jacobsen, J Chuck Harrell, Paul Jedlicka, et al.
The Lancet. Oncology|May 29, 2018
Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b studyRashmi Murthy, Virginia F Borges, Alison Conlin, et al.
NPJ Breast Cancer|October 22, 2020
Semaphorin 7a is a biomarker for recurrence in postpartum breast cancerVirginia F Borges, Junxiao Hu, Chloe Young, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 14, 2017
The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?Jagar Jasem, Christine M Fisher, Arya Amini, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2017
Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patientsKimberly R Jordan, Puja Kapoor, Eric Spongberg, et al.
Breast Cancer Research and Treatment|February 24, 2021
Real-world evidence from a University Hospital system regarding the uptake of adjuvant pertuzumab and/or neratinib before and after their FDA approvalEricson Stoen, Jodi Kagihara, Elena Shagisultanova, et al.
Neuro-Oncology|February 6, 2014
Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edemaJulie A Carlson, Zohra Nooruddin, Chad Rusthoven, et al.
Nutrition and Cancer|June 22, 2025
Comparing Appetite and Dietary Intake Responses to Resistance Exercise in Breast Cancer Survivors Undergoing Adjuvant Endocrine Therapy Versus Individuals Without Cancer: A Secondary AnalysisSarah A Purcell, Tanya M Halliday, Edward L Melanson, et al.
Pageof 16

Showing results (31-40 of 154) with videos related to

Sort By:
Pageof 16
Appetite|December 20, 2022
The effects of resistance exercise on appetite sensations, appetite related hormones and energy intake in hormone receptor-positive breast cancer survivorsSarah A Purcell, Edward L Melanson, Anosheh Afghahi, et al.
Oncology (Williston Park, N.Y.)|September 20, 2015
Multiple Hepatic Lesions in a Patient With a History of DCISJagar Jasem, Basel Altoos, Christine M Fisher, et al.
Cancer Research|August 17, 2006
Spontaneous fusion with, and transformation of mouse stroma by, malignant human breast cancer epitheliumBritta M Jacobsen, J Chuck Harrell, Paul Jedlicka, et al.
The Lancet. Oncology|May 29, 2018
Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b studyRashmi Murthy, Virginia F Borges, Alison Conlin, et al.
NPJ Breast Cancer|October 22, 2020
Semaphorin 7a is a biomarker for recurrence in postpartum breast cancerVirginia F Borges, Junxiao Hu, Chloe Young, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 14, 2017
The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?Jagar Jasem, Christine M Fisher, Arya Amini, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2017
Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patientsKimberly R Jordan, Puja Kapoor, Eric Spongberg, et al.
Breast Cancer Research and Treatment|February 24, 2021
Real-world evidence from a University Hospital system regarding the uptake of adjuvant pertuzumab and/or neratinib before and after their FDA approvalEricson Stoen, Jodi Kagihara, Elena Shagisultanova, et al.
Neuro-Oncology|February 6, 2014
Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edemaJulie A Carlson, Zohra Nooruddin, Chad Rusthoven, et al.
Nutrition and Cancer|June 22, 2025
Comparing Appetite and Dietary Intake Responses to Resistance Exercise in Breast Cancer Survivors Undergoing Adjuvant Endocrine Therapy Versus Individuals Without Cancer: A Secondary AnalysisSarah A Purcell, Tanya M Halliday, Edward L Melanson, et al.
Pageof 16